ALPMY
Price
$9.93
Change
+$0.01 (+0.10%)
Updated
Jun 3 closing price
Capitalization
26.55B
56 days until earnings call
OPHLY
Price
$3.53
Change
-$0.03 (-0.84%)
Updated
Jun 3 closing price
Capitalization
9.02B
61 days until earnings call
Interact to see
Advertisement

ALPMY vs OPHLY

Header iconALPMY vs OPHLY Comparison
Open Charts ALPMY vs OPHLYBanner chart's image
Astellas Pharma
Price$9.93
Change+$0.01 (+0.10%)
Volume$167.68K
Capitalization26.55B
Ono Pharmaceutical
Price$3.53
Change-$0.03 (-0.84%)
Volume$153.58K
Capitalization9.02B
ALPMY vs OPHLY Comparison Chart
Loading...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMY vs. OPHLY commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMY is a Buy and OPHLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (ALPMY: $9.87 vs. OPHLY: $3.53)
Brand notoriety: ALPMY and OPHLY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMY: 31% vs. OPHLY: 76%
Market capitalization -- ALPMY: $26.55B vs. OPHLY: $9.02B
ALPMY [@Pharmaceuticals: Major] is valued at $26.55B. OPHLY’s [@Pharmaceuticals: Major] market capitalization is $9.02B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMY’s FA Score shows that 1 FA rating(s) are green whileOPHLY’s FA Score has 3 green FA rating(s).

  • ALPMY’s FA Score: 1 green, 4 red.
  • OPHLY’s FA Score: 3 green, 2 red.
According to our system of comparison, OPHLY is a better buy in the long-term than ALPMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMY’s TA Score shows that 8 TA indicator(s) are bullish while OPHLY’s TA Score has 3 bullish TA indicator(s).

  • ALPMY’s TA Score: 8 bullish, 2 bearish.
  • OPHLY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALPMY is a better buy in the short-term than OPHLY.

Price Growth

ALPMY (@Pharmaceuticals: Major) experienced а +2.39% price change this week, while OPHLY (@Pharmaceuticals: Major) price change was +0.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.27%. For the same industry, the average monthly price growth was +2.61%, and the average quarterly price growth was +3.54%.

Reported Earning Dates

ALPMY is expected to report earnings on Jul 30, 2025.

OPHLY is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+3.27% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALPMY($26.6B) has a higher market cap than OPHLY($9.03B). ALPMY has higher P/E ratio than OPHLY: ALPMY (37.59) vs OPHLY (11.40). ALPMY YTD gains are higher at: 2.795 vs. OPHLY (1.437). ALPMY has higher annual earnings (EBITDA): 247B vs. OPHLY (162B). ALPMY has more cash in the bank: 397B vs. OPHLY (164B). OPHLY has less debt than ALPMY: OPHLY (9.17B) vs ALPMY (30B). ALPMY has higher revenues than OPHLY: ALPMY (1.52T) vs OPHLY (447B).
ALPMYOPHLYALPMY / OPHLY
Capitalization26.6B9.03B295%
EBITDA247B162B152%
Gain YTD2.7951.437195%
P/E Ratio37.5911.40330%
Revenue1.52T447B340%
Total Cash397B164B242%
Total Debt30B9.17B327%
FUNDAMENTALS RATINGS
ALPMY vs OPHLY: Fundamental Ratings
ALPMY
OPHLY
OUTLOOK RATING
1..100
855
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10010
PRICE GROWTH RATING
1..100
5776
P/E GROWTH RATING
1..100
9812
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OPHLY's Valuation (20) in the null industry is in the same range as ALPMY (21). This means that OPHLY’s stock grew similarly to ALPMY’s over the last 12 months.

OPHLY's Profit vs Risk Rating (100) in the null industry is in the same range as ALPMY (100). This means that OPHLY’s stock grew similarly to ALPMY’s over the last 12 months.

OPHLY's SMR Rating (10) in the null industry is significantly better than the same rating for ALPMY (100). This means that OPHLY’s stock grew significantly faster than ALPMY’s over the last 12 months.

ALPMY's Price Growth Rating (57) in the null industry is in the same range as OPHLY (76). This means that ALPMY’s stock grew similarly to OPHLY’s over the last 12 months.

OPHLY's P/E Growth Rating (12) in the null industry is significantly better than the same rating for ALPMY (98). This means that OPHLY’s stock grew significantly faster than ALPMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMYOPHLY
RSI
ODDS (%)
Bullish Trend 2 days ago
54%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 6 days ago
51%
Declines
ODDS (%)
Bearish Trend 22 days ago
69%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
56%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SUIAX57.47N/A
N/A
DWS CROCI International A
HQISX20.64N/A
N/A
Hartford Equity Income R4
WFINX53.98N/A
N/A
Allspring Index C
MGPIX102.15N/A
N/A
ProFunds Mid Cap Growth Inv
NELCX50.90N/A
N/A
Nuveen Equity Long/Short C

ALPMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMY has been loosely correlated with ALPMF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMY jumps, then ALPMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMY
1D Price
Change %
ALPMY100%
+0.10%
ALPMF - ALPMY
38%
Loosely correlated
+7.92%
OPHLY - ALPMY
33%
Loosely correlated
-0.84%
CHGCY - ALPMY
22%
Poorly correlated
-4.16%
DSNKY - ALPMY
21%
Poorly correlated
-4.52%
OTSKY - ALPMY
20%
Poorly correlated
-3.15%
More

OPHLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPHLY has been loosely correlated with OTSKY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPHLY jumps, then OTSKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPHLY
1D Price
Change %
OPHLY100%
-0.84%
OTSKY - OPHLY
42%
Loosely correlated
-3.15%
ALPMY - OPHLY
36%
Loosely correlated
+0.10%
CHGCY - OPHLY
26%
Poorly correlated
-4.16%
BAYRY - OPHLY
22%
Poorly correlated
-1.66%
OPHLF - OPHLY
14%
Poorly correlated
N/A
More